Navigation Links
Cardica to Host Investor Briefing on 'Revolutionizing Revascularization'
Date:6/9/2008

- Event to Be Webcast June 12 at 5:15 p.m. Eastern Time - - PAS-Port(R) System Clinical Data To Be Presented During Late Breaking News Session of International Society for Minimally Invasive Cardiothoracic

Surgery Annual Meeting -

REDWOOD CITY, Calif., June 9 /PRNewswire-FirstCall/ -- Cardica, Inc. (Nasdaq: CRDC) today announced that it will webcast an investor briefing on the topic of "Revolutionizing Revascularization" on Thursday, June 12, at 5:15 p.m. Eastern Time in Boston. The event will feature a panel of renowned cardiovascular surgeons who will discuss how surgeons are integrating new techniques to improve coronary artery bypass graft (CABG) procedures, including the use of Cardica's C-Port(R) Distal Anastomosis Systems, which are designed to allow surgeons to automate the attachment of blood vessel grafts during CABG procedures, replacing traditional hand-sewn sutures.

The Company also announced that data from the 220-patient prospective, randomized pivotal clinical trial of its PAS-Port(R) Proximal Anastomosis System will be presented at the 2008 Annual Scientific Meeting of the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) in Boston. The presentation, entitled "The Cardica PAS-Port Proximal Anastomotic Connector Device: First Report of the Results of the FDA Trial," will be given during the Late Breaking News session on Thursday, June 12, at 1:15 p.m. Eastern Time by principal study investigator John D. Puskas, M.D., chief of cardiac surgery at Emory Crawford Long Hospital in Atlanta. As previously announced, the trial, which compared graft vessel connections made using the PAS-Port system to conventional hand-sewn sutures during CABG procedures, a
'/>"/>

SOURCE Cardica, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cardica Reports Positive Top-Line Results and Submits 510(k) for PAS-Port(R) Proximal Anastomosis System in Cardiac Bypass Surgery
2. Exelixis Announces September 5 Webcast of Its 2007 IASLC Investor and Analyst Briefing
3. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
4. Oculus Innovative Sciences to Present at 4th Annual BIO InvestorForum Conference
5. BD to Present at Investor Healthcare Conferences
6. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
7. Pharmacopeia to Present at BIO CEO & Investor Conference 2008
8. CoAxia(TM) Announces $11.5M Equity Financing From Existing Investors
9. Hospital to Hold MRSA Briefing for Media and Community Leaders
10. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
11. CPR Data Debriefing by Hospital Responders Improves CPR Performance and Increases Initial Survival Rate Following Cardiac Arrest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)...  Eli Lilly and Company (NYSE: ... study in genetically engineered mice examining combination therapy ... N3pG and beta-secretase inhibitor BACE (LY2811376). Data results ... removing clumps of amyloid-beta protein in the brain ... to Alzheimer,s disease (AD) – than use of ...
(Date:7/11/2014)... ANGELES , July 11, 2014 /PRNewswire-iReach/ -- ... e-liquid, a vegetable-glycol solution for use in portable ... of the active ingredients in cannabis, cannabidiol offers ... personal vaporizer devices, and other vaporizer technology. ... Cannabis naturally contains 483 different compounds which ...
(Date:7/11/2014)... HILL, N.C. , July 11, 2014 /PRNewswire/ ... of pharmaceutical marketing and, consequently, organizations are turning ... for patients. As part of this ... it,s important to educate, communicate and engage patients ... disease awareness to patient empowerment. By mapping the ...
Breaking Medicine Technology:New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2
... , , SILVER SPRING, Md. , Feb. ... approved Xiaflex (collagenase clostridium histolyticum) as the first drug to ... can affect a person,s ability to straighten and properly use ... affects the connective tissue found beneath the skin in the ...
... 2 Vermillion, Inc. (Pink Sheets: VRML) today announced the reappointment ... Company and Eric T. Fung , MD, PhD as Senior Vice ... announced appointment of William C. Wallen , PhD to the Board ... Chair of the Board of Directors. , "Both Dr. Fung and I ...
Cached Medicine Technology:FDA Approves Xiaflex for Debilitating Hand Condition 2Vermillion Announces the Reappointment of Officers and Confirmation of Director 2Vermillion Announces the Reappointment of Officers and Confirmation of Director 3Vermillion Announces the Reappointment of Officers and Confirmation of Director 4
(Date:7/13/2014)... 13, 2014 Fuel additives are chemicals, ... diesel, jet fuel, kerosene, and so on, in order ... for reducing the corrosion effects caused by fuels and ... to any fuel, provide economies of scale in the ... the overall cost of the fuel products. , The ...
(Date:7/13/2014)... 13, 2014 According to a ... Computing Market by Component (processor, GPU, DSP, connectivity), ... Medical), and Geography - Forecast and Analysis to ... Processing & Computing Market is expected to reach ... of 20.75% from 2014 to 2020. , Browse ...
(Date:7/13/2014)... MarketsandMarkets recently conducted a study ... Scanning; 3D rendering; Layout and Animation; Image Reconstruction]: ... 2018)”, which analyzes and studies the major market ... Europe, Eastern Europe, Middle East and Africa, Asia-Pacific ... competitive landscape of the 3D imaging market, providing ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 A Massachusetts ... to the cancer risks associated with power morcellators ( ... their story to federal regulators, as they presented poignant ... Food & Drug Administration (FDA) advisory panel meeting convened ... According to the Rochester Democrat and Chronicle, Dr. Hooman ...
(Date:7/13/2014)... HealthDay Reporter FRIDAY, July 11, ... for people with diabetes is being developed to measure sugar ... report. Scientists at Brown University in Providence, R.I., created ... uses light, metal and a special enzyme that changes color ... have to prick their fingers to draw blood to check ...
Breaking Medicine News(10 mins):Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 3Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 4Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 4Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 2Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 3Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 4Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 2Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 3Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 4Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 2Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 3
... lung cancer (NSCLC), the most common form of lung ... a small group of patients can also be helped ... published in BioMed Central,s open access journal BMC ... factor receptor (EGFR) using RNAi, alongside TKI (or antibody ...
... kind, a consortium of investigators from 13 countries led the ... the Catholic University of Leuven, Belgium in Europe, found that ... likelihood of leaving also had patients who were more satisfied ... The study was released today in the current issue of ...
... HealthDay Reporter , TUESDAY, March 20 (HealthDay News) -- ... epinephrine -- adrenaline -- might do more harm than ... of hundreds of thousands of cases. Japanese researchers ... likely to survive one month, compared with those who ...
... such as kidney failure and endocrine tumors are among ... the common pain relievers in your medicine cabinet be ... Tel Aviv University,s Sackler Faculty of Medicine and the ... are underlying causes of hypertension, which is a major ...
... , TUESDAY, March 20 (HealthDay News) -- Insects ... Chagas disease are well-established and feeding on human blood in ... What remains a mystery, however, is why the insects ... a serious condition that can lead to life-threatening digestive and ...
... , TUESDAY, March 20 (HealthDay News) -- The ... of altitude sickness, according to a new study. ... among the symptoms of altitude sickness, which affects more ... elevations each year to ski, hike or camp. ...
Cached Medicine News:Health News:Double whammy: RNAi enhances lung cancer therapy 2Health News:International research finds quality and safety problems in hospitals throughout 13 countries 2Health News:Adrenaline Therapy for Cardiac Arrest Linked to Worse Outcomes 2Health News:Adrenaline Therapy for Cardiac Arrest Linked to Worse Outcomes 3Health News:Pain relievers could be spiking your blood pressure 2Health News:Insects Behind Chagas Disease Are Feeding on Humans in the U.S. 2Health News:Ibuprofen May Ward Off Altitude Sickness 2
Intermittent catheter...
Intermittent catheter...
Intermittent catheter...
... The new Finnpipette Focus from Thermo Labsystems ... uncompromising performance. Advanced features such as ... fine volume adjustment on microvolumes help to ... single channel pipettes. The new interchangeable handle ...
Medicine Products: